Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06254794 · ClinicalTrials.gov registry record · NA

Effect of BFR Rehab After Achilles Tendon Rupture

A NA study of Achilles Tendon Rupture, sponsored by The Methodist Hospital Research Institute.

Recruiting
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT06254794 is a NA study of Achilles Tendon Rupture that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 19 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06254794, a NA study of Achilles Tendon Rupture, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.

RECRUITING
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if blood flow restriction therapy after Achilles tendon rupture reconstruction decreases post-operative calf atrophy, improves reported outcomes, and ultimately decreases return to play time.

Conditions Studied

Interventions

  • OTHER Physical therapy
  • DEVICE Blood flow restriction with Delfi Personalized Tourniquet System (PTS)

Study Locations (1)

Texas

  • Houston Methodist Hospital - Houston

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2018-11-13
Est. Completion 2028-12
Phase NA

What the Registry Record Tells You About NCT06254794

The ClinicalTrials.gov registry entry for NCT06254794 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Achilles Tendon Rupture appearing as the primary indexed condition, and to 2 interventions - of which Physical therapy is the first listed.

NCT06254794 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06254794 about?

NCT06254794 is a clinical study titled "Effect of BFR Rehab After Achilles Tendon Rupture". The purpose of this study is to determine if blood flow restriction therapy after Achilles tendon rupture reconstruction decreases post-operative calf atrophy, improves reported outcomes, and ultimately decreases return to play time.

What is the current status of trial NCT06254794?

This trial is currently recruiting. It is a NA study. The enrollment target is 19 participants. The study started on 2018-11-13. Estimated completion is 2028-12.

What conditions does trial NCT06254794 study?

This clinical trial studies the following conditions: Achilles Tendon Rupture.

What interventions are being tested in trial NCT06254794?

The interventions under investigation include: Physical therapy (OTHER), Blood flow restriction with Delfi Personalized Tourniquet System (PTS) (DEVICE).

Who is sponsoring clinical trial NCT06254794?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06254794 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Achilles Tendon Rupture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.